Mettler-Toledo International Inc (MTD)

Mettler-Toledo International Inc (MTD) carries a ŷRobot AI score of 54 out of 100. The model's fair value estimate is $1,533.66, 0.4% above the last close of $1,527.77. The chart signal reads Sell.

MetricMTD
AI score54 / 100
Chart signalSell
Fair value estimate$1,533.66
Upside to fair value0.4%
Previous close$1,527.77
P/E34.60
Price / sales7.18
Market cap$30.89B
EPS44.43
Revenue growth1.0%
1-year price change0.0%

How these numbers are built: the AI score, the fair value model, and the chart signal.

Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.

Questions about MTD

Is MTD overvalued or undervalued right now?

As of Oct 8, 2026, ŷRobot's fair-value model estimates Mettler-Toledo International Inc (MTD) at $1533.66 against a last close of $1527.77, implying 0.4% upside to the model's estimate.

Is MTD's chart signal bullish or bearish?

The chart-signal model classifies MTD as Neutral as of Oct 8, 2026, with a signal score of -0.11 on a -1 to 1 scale.

What is MTD's ŷRobot AI score?

MTD scores 54 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 8, 2026.

Is MTD stock expensive on P/E and P/S?

MTD trades at 34.6 times earnings and 7.2 times sales as of Oct 8, 2026.

What does MTD's seasonal forecast show?

ŷRobot's seasonal forecast curve for MTD reads +0.5% at 30 days, +5.1% at 90 days, and +0.0% at one year as of Oct 8, 2026. Seasonal tendencies are historical patterns, not predictions.

How fast is MTD growing?

Mettler-Toledo International Inc's revenue growth is +1.0% and free-cash-flow growth is -3.1% on the latest reported figures.

MTD chart and technical read · All covered stocks

ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.